Lynne Hughes has worked in clinical research for more than 33 years and has lived and worked during this time period in both the US and in Europe. She has been with IQVIA for 21 years and is currently Vice President and Global Head, Medical Strategy, Neurology. She has provided consultancy advice in Alzheimer’s disease, multiple sclerosis, acute care including TBI and stroke, migraine, epilepsy and pain, and has been involved in a number of investment opportunities within IQVIA. She sits on a number of advisory boards, with particular interest in neurocognitive assessment and design of appropriate studies to assess AD & neurocognitive dysfunction. She is a member of a number of steering and / or executive committees for clients and has responsibility for several consultancy programs for investment opportunities within all areas of neurology. Her current role is in developing evidence-based strategies for the most efficient conduct of clinical trials / programs for our clients and leads the Medical Strategy team which provides therapeutic input and expertise for conducting trials in subjects across all neurological and pain indications. She has been involved, to varying extents, in the development of every neurology product on the market today. She has been involved in all of IQVIAs AD trials – and this is more than 82 trials, many of which were global, over the past 10 years. She is PMP certified and has been since 2000 and this certification is up to date.

Alzheimer’s disease, Parkinson’s disease, Neurocognitive dysfunction.

Sam Vaknin is the author of Malignant Self-love: Narcissism Revisited as well as many other books and ebooks about topics in psychology, relationships, philosophy, economics, international affairs, and award-winning short fiction. He is Visiting Professor of Psychology, Southern Federal University, Rostov-on-Don, Russia and Professor of Finance and Psychology in CIAPS (Centre for International Advanced and Professional Studies). He was the Editor-in-Chief of Global Politician and served as a columnist for Central Europe Review, PopMatters, eBookWeb , and Bellaonline, and as a United Press International (UPI) Senior Business Correspondent. He was the editor of mental health and Central East Europe categories in The Open Directory and Suite101. His YouTube channels garnered 20,000,000 views and 85,000 subscribers. Currently, Sam Vaknin is the editorial board member of the following journals: Global Journal of Addiction and Rehabilitation Medicine, Journal of Clinical Review & Case Reports, Journal of Psychology Research, Journal of Neurology, Psychiatry, and Brain Research, Journal of Clinical Depression, Journal of Asclepius Medical Case Reports, Journal of Psychology and Psychiatry Studies.

Personality Disorders

John L Merritt graduated from the Medical University of South Carolina (MD) and did residencies at Huntington Hospital (University of Southern California) and The Mayo Clinic, Rochester Minnesota. He is an Emeritus Professor, University of South Florida, Medicine & Neurology, and has served as Professor at the Mayo Clinic, University of Southern California, Irvine, Medical College of Wisconsin and University of South Florida, Tampa. He is board certifi ed in Brain Injury Medicine, Spinal Cord Medicine, Physical Medicine & Rehabilitation and Internal Medicine. He is Medical Advisor to Stay in Step SCI Recovery Center and President of RehabMed South

Neuro-regeneration, Olfactory Mucosal Autografts, Stem Cell Therapies Spinal Cord Injury Acute and Chronic, Outcomes; Prevention of Urinary Tract Infections Prevention of Urinary Tract Infection in Spinal Cord Injury Pressure Ulcer Prevention and Management; Respiratory Intervention in Quadriplegia Energy Expenditure in Paraplegia; Metabolic Changes in Chronic SCI Ethics, Beginning and End of Life Issues, Palliative Care Amyotrophic Lateral Sclerosis, Outcome Prediction and Management Life Expectancy and Outcomes in Spinal Cord Injury

Prof.Jan VERSIJPT is the Neurologist and Head of the Clinic for Head and Face Pain in the Brussels University Hospital.

Neurology, Dementia

Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, graduated from Tehran University, School of Medicine with honor. He studied in neurosurgery ward and graduated with A score with a thesis on Meningioma Brain Tumor during 6 years. With continuing his practice with special consideration on psychosomatic disorders, he completed many postgraduate courses on health psychology, addiction medicine, sexual disorders therapy successfully. Dr. Mojtaba passed many postgraduate courses in Neuro, approved by Medical sciences university. As well, he has been passed postgraduate courses on Nutrition, Gastroenterology and Hepatology, Obesity treatment and diabetes approved by the Medical sciences university of Tehran. Having honor of working as an associate of Iran Hepatitis Network and Gastroenterology and Hepatology research center, Middle East Liver Diseases Center (MELD). He published reviews for articles on Brain Tumor Immunotherapy, CNS Tumor Guideline and Alzheimer disease in Elsevier and Kudos. His review on Alzheimer's disease article with specific DOI was published in American Physiological Society.

Neuro-oncology, Neurosurgery specialized in Brain tumors and Meningioma

Dr. Ramesh Gupta is Vice Chancellor of Radha Govind University Ramghar, Jharkhand India. Before joining this place for 40 years, Prof Gupta was professor & Pro Vice chancellor at Nagaland central University India He received at the age of 23, his Doctorate in Chemistry at Lucknow University, on Drug Development. Dr. Ramesh Gupta is a Medicinal & Bioorganic Chemist and has worked for several years as visiting professor/Scientist in various Medical schools; Louis pasture University France, University of Arizona USA, Osaka University & Nagoya University Japan, Kyung Hee University, Korea advance institute of science and technology (KAIST) Korea, Ben-Gurion University Israel, Linkoping University Sweden, University of Mons Belgium, University of Western Australia, Sydney ,University of Bergen ,Norway and some others.

Natural & Synthetic Drug Development, role of sulfur amino acids in health care, functional food, nutraceuticals and environmental Biotechnology & gender issues.

Prof.Dr. C.P Abdolrasoul Aleezaadeh completed his Post Doctorate in (Psychology) at Approach of: Applied Clinical Cognitive Neuropsychology from USA. Prof. Dr. Aleezaadeh Completed his PhD Degrees in Psychology at the USA. He completed his Master's Degree in Clinical Psychology at I. R. of the IRAN, Bachelor's Degree in General Psychology at I. R. of the IRAN, Bachelor's Degree in Homeopathic Medicine - I.R of IRAN (Berkeley International University - the USA) and, Advanced Curriculum in Traditional Medicine at W.M.C -I.R of IRAN (Tibbia College Gujranwala - Pakistan). Also, he has five Certificates/Documents in e-Marketing, Marketing, Marketing Management, Sales Management and, Sales Management (A Global Perspective) at Cavendish Caramad Institute - I.R of IRAN (Cavendish College - the UK) and, Instructor of first aid (initial, complementary and specialized). He is Full Expert International Faculty Professorship Member in the Brooklyn Central University, the USA, Associate Expert International Faculty Professorship Member in the University of Pacific Albion, the USA and, Associate Expert International Faculty Professorship Member in the Green Lake (Green Lake) University, the USA. Now he is working as an Assistant Professor at P.N.U and, U.A.S.T Universities; I.R. of IRAN

Cognitive Sciences, Cognitive Neurosciences, Neuroimaging, Applied Clinical Neuropsychology, Brain (Cranial) Imaging, Traditional Medicine, Homeopathic Medicine and, Combination of Medical and Psychological trends for eradicating illnesses / sicknesses, Psychology, Cognitive Neuropsychology; Addiction Neurophysiology and, Neuropsychology, Biotechnological Researches, Nutrition and, Nutrient Industries, Psychopharmacology, Traditional Medicine Herbals/Medicinal Plants, Homeopathic Medicine Remedies

Ivan Milanov is Director & Professor at the University Neurological Hospital “St. Naum”, Department of Movement Disorders and Chief of Neurological clinic of Movement Disorders. He is the Consultant of the Ministry of Health. Member of the Governmental commission for the positive drug list of Bulgaria for 3 mandates.He is the President of theBulgarian Neurological Society, Bulgarian Movement Disorders and Multiple Sclerosis Society, Bulgarian Headache and Pain Society, Bulgarian Society of Clinical Electromyography, Vice President of the Bulgarian Association of Neuroprotection and Neurodegeneration.

Headache,Back pain, Movement Disorders, Parkinson’s disease, Multiple sclerosis, Sleep disorders and anxiety, Clinical electromyography, Botox treatment

Dr. Drini DOBI was born in January 27th, 1969, and graduated as PhD in University of Tirana, Albania in 1992, and has done the specialization course in Neurology from 1994-1998 in University Hospital Centre "Mother Teresa", Tirana Albania. After his specialization, he has done some other minispecialization course for neurorehabilitation in Instituto Carlo Besta, Milano, Italy, San Carlo , Milan, Italy and Don Carlo Gnocchi Milano, Italy and minispecialization course for neurosonology in UHC "Sestre Milosrdnice" Zagreb, Croatia. He has a lot of publications in some medical periodics and has participated in some of AAN Annual Meetings with his works, EFNS and EAN conferences, with his works too, and some other Neurological Conferences abroad. His Masters is in Rehabilitation in Parkinson Disease, in 2005 and PhD in Physical Rehabilitation after stroke in 2015. He is also the Member of EAN Scientific Pannel of Neurorehabilitation ,Scientific Pannel of neurotoxicology, and General Neurology

Neurorehabilitation and Stroke

Dr. E. Faizo. is a certified licensed Medical Doctor specialized in Neurosurgery and spine surgery practicing in Murnau Hospital south Germany. He presented in international seminars, media interviews and conferences in Health Care and education. Member of the Advisory boards in many German medical companies. Member of the German and European Neurosurgical Societies.

Spine surgery in research and pain therapy , Neuromodulation

Dr.Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007

Neurology, Neuroradiology, Epidemiology

He founded SGNP Ltd - Neuro Therapy Specialist Services and Stroke & Brain Injury Specialist Services UK in early 2013 after years of successful Neuro Physiotherapy practice both in the NHS and privately. As Neuro Physiotherapist and Rehabilitation Director of SGNP Ltd he is responsible for clients with complex needs and background due to neurological conditions particularly Brain Injury & Stroke. He designs and update rehabilitation programs with the aim of maximising the functional outcomes of clients to bring them as close as possible to their previous level of functioning.

Neurological Physiotherapy & Occupational Therapy, Rehabilitation

Bachelor and Master in Clinical and Health Psychology at Aveiro University (Portugal) and internship in Coimbra Hospital University Centre (e.g., Intervention in Sleep Disorders and Pain Disorders). Later, worked as a psychologist and neuropsychologist. Also performed a research project in Biofeedback/Neurofeedback by the Foundation for Science and Technology (FCT). Concomitantly, made several national and international communications in various Congress as Guest Speaker in the field of Neuroscience. Editor in Chief and Founder of the International Journal of Psychology and Neuroscience and Editor in several Scientific Journals and Author of various articles in peer review journals. At the moment, is a Ph.D. student in Neuroscience at the Faculty of Medicine, University of Salamanca – Neurosciences Institute of Castilla y León

Experimental Psychology, Neuropsychology and Biological Rhythms, particularly in: Assessment and Neuropsychological Rehabilitation, Drug Abuse and Addiction, Behavioural

Dr.Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007.

Neurology, Neuroradiology, Epidemiology

George Perry (born April 12, 1953 in Lompoc, California) is a neuroscientist recognized in the field of Alzheimer's disease research particularly for his work in oxidative stress. Dr. Perry has studied at many universities and holds multiple degrees including a Bachelor of Arts degree in Zoology from the University of California Santa Barbara and a PhD in Marine Biology from the Scripps Institution of Oceanography at San Diego. He is distinguished as one of the top Alzheimer’s disease researchers by Expertscape with over 1000 publications, more than 67,000 citations (H=130), one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in free radical research. Dr. Perry is a Semmes Foundation Distinguished University Chair in Neurobiology and is an active participant in many other scientific associations. He is an elected member of the Academies of Sciences of Mexico, Portugal, and Spain. In addition, Perry is an Editor of numerous scientific journals including Journal of Alzheimer’s Disease which he founded in 1998. Today, Perry continues his love for research while working as Dean of the College of Sciences at The University of Texas at San Antonio.

In the field of Alzheimer's disease research and oxidative stress.

Dr.P.Nagaraj has completed his Ph.D,FRHS., at the age of 35 years from Open International University and University of Madras. He is the Director and chief consultant of PMN Pranikha Speciaality clinic, Chennai, India., a premier Orthopaedic Neuro & Sports Medicine Rehabilitation clinic. He has published more than 25 papers in reputed journals and has been serving as an editorial board member of Indian Sports ,Ghaziabad,UP,India..and Various Sports Associations And Federations In India In Both Domestic And International Committees

In the field of Orthopaedic Neuro & Sports Medicine Rehabilitation.

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong

His main research areas are Neuropsychiatry in Stroke, Substance abuse, Postnatal depression, dementia, cognitive impairment, depression, anxiety, apathy, fatigue, emotional incontinence, suicidality, insomnia, pain, and quality of life. Other research areas include psychiatric morbidity in Pneumoconiosis and Parkinson’s disease, Electroconvulsive Therapy, Schizophrenia and Psychogeriatrics

Mohammad Nazrul Hossain, passed MBBS from Sir Salimullah Medical College, Dhaka, Bangladesh in 2000. He got his fellowship in Neurosurgery from Bangladesh College of Physician and Surgeons (BCPS) in 2012.He was the first fellow in his subject from BCPS.His study was acknowledged by the BCPS and published in their journal. After successful completion of his fellowship he joined and worked in a world renowned chain hospital “APOLLO”, Dhaka, Bangladesh as neurosurgeon. During his neurosurgical carrier he worked with famous neurosurgeons of both national and international level. He joined “Jalalabad Ragib-Rabeya Medical College and Hospital” from Apollo in 2013 and established a fully new Neurosurgery department and serving the people of this area with their satisfaction.

Neurosurgery,

Dr.Burton M. Altura is currently working as a Professor of Physiology, Pharmacology & Medicine State University of New York Downstate Medical Center. He completed his PhD from Newyork University School of Medicine. He published many articles. Dr. Burton M. Altura studies address the two most important issues in vascular biology today: stroke mechanisms; and irreversible cellular destruction in the cardiovascular system caused by alcohol and substance abuse. These studies have already led to the prevention of atherosclerotic lesions, hypertension and stroke-like events in experimental animal models.

Our overall interest is the role of magnesium, sphingolipids and lipid messengers in vascular biology and disease processes, such as stroke, diabetes mellitus and atherogenesis. An additional major interest is the role of alcohol and substances of abuse in stroke etiology. To accomplish these ends, whole animals, human subjects, tissues and cell culture techniques are utilized.

Lucia-Maria Vaina combines psychophysics, multimodal neuroimaging (fMRI and MEG), and computational modeling to study plasticity and the spatiotemporal orchestration of the visually eloquent system in humans. She trained first in mathematics&applied mathematics, and received her first PhD from the Sorbonne, in 1977, she underwent postdoctoral training at Berkeley (with Lotfi Zadeh) , Stanford (with Patrick Suppes) and Massachusetts Institute of Technology (with Marvin Minsky), before getting her MDPhD at the University of Toulouse, and training in neurology at Beth Israel Hospital in Boston under Norman Geshwind and at the Boston VA under Harold Goodglass. Dr. Vaina is currently Professor of Neurology, Biomedical Engineering and Neuroscience at Boston University and on the faculty faculty at Harvard Medical School, Departments of Neurology&Radiology. She is Director of Brain and Vision Laboratory (BRAVI) (http://www.bu.edu/bravi/) at Boston University and co-director of the Neurology of Vision Laboratory (NOVI) at Massachusetts General Hospital, Harvard medical School.She worked at New England Rehabilitation Hospital, Young Stroke Unit and Brain Injury Unit , until 1997 when she moved to Massachusetts General Hospital-Neurology Department & Martinos Center for Biomedical Imaging. She has served as expert witness defending Brain Injury patients with acquired cognitive and perceptual deficits.

Dr. Vaina main areas of current interest involve: (a) models of visual motion analysis in the human brain based on computational, psychophysical, structural and functional-neuroanatomical methods; (b) functional plasticity-learning and neurocovery: physchophysics, functional neuroimaging and neuronal network models; (c) Functional MRI of the human visual system.

Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration.

Parkinsion’s and Alzheimer’s Diseases

Ateeq Ahmad, Ph.D. is vice president for science & technology at Jina pharmaceuticals, Inc., USA. Prior to joining Jina in 2006, Dr. Ahmad worked at Neopharm, Inc., Pharmacia (Searle), Sanofi, J &J, Medarex, Biotherapeutics and National Institutes of Health. He has more than 30 years of experience in drug discovery, drug targeting, therapeutic proteins, immunotoxins, liposomes and clinical pharmacology. Currently, Dr. Ahmad is directing drug development program including safety assessment, efficacy evaluation and pharmacokinetics of drug candidates for cancer therapeutics and neurological disorders. He has authored 61 original articles in peer reviewed scientific journals.

Drug discovery, drug targeting, therapeutic proteins, immunotoxins, liposomes and clinical pharmacology

Sanjoy Sanyal is Associate Dean, Clinical Neuroscience Professor, Surgeon and Informatician in Texila American University, Guyana, South America. He holds double Master's degrees from India and UK. He has published more than 50 papers in print and online journals. He is a Neuroscience editor and peer-reviewer of WebmedCentral. He has posted more than 300 Neuroscience videos online, accompanied by his running commentaries. He is currently writing a Neuroscience book for medical students. He has presented papers in more than 10 international forums. He holds a provisional patent from USPTO on a computerized program for staging 26 human cancers.

Schizophrenia and Bipolar disorder

In 1993 Kerensa started her study nutrition and dietetics in Amsterdam. After finishing the bachelor in 1997, she continued with a master degree nutrition and food management at Huddersfield University in the UK. From 2000 until 2005 she worked as a PhD student at Wageningen University on the biophysics of unfolding, refolding and aggregation of food related proteins. Her first postdoctoral work was at the Medical Research Council – Laboratory of Molecular Biology in the Neurobiology department in Cambridge, UK. This work focused on fatty acid – a-synuclein interactions employing both biophysics and cell culture as research tools. Her second postdoc was at the Free University of Brussels (VUB) in Belgium where she started working on the role of amyloid beta peptide in Alzheimer’s disease. Here she also obtained an Odysseus grant from the Belgian government and, as a result of that, was offered a position as assistant professor. Kerensa moved to her current position as an assistant professor at the University of Twente in March 2011. She prefers to spend her spare time in the dojo doing karate, travelling, gardening or reading.

Alzheimer’s, Parkinson’s disease, prion diseases

Dr. Hernández, Ph.D. has been studying traumatic brain injury (TBI) using basic and clinical neuroscience models since 1985. Her ongoing, extramurally funded research program assesses the degree to which recovery and functional outcome after TBI can be optimized in a variety of populations (Veterans, civilians, athletes). This includes conducting randomized, placebo-controlled, blinded trials of novel interventions, such as acupressure. This work is accomplished through her appointment as Professor and Chair of the Department of Psychology & Neuroscience at CU Boulder, her appointment as a Senior Investigator and Research Psychologist in the Eastern Colorado Healthcare System, Rocky Mountain MIRECC (Mental Illness, Research, Education & Clinical Center) and through her role as one of the co-Directors of the PAPRR (Promoting Athlete Performance, Recovery and Resilience) Board at CU Boulder. She is also the Director of the CAIRR (Clinical Assessment of Injury, Recovery and Resilience) Neuroscience Laboratory.

Research is aimed at providing an experimental basis for improving clinical treatment following brain insult so that neurobehavioral function is optimized. We are currently accomplishing this via two tracks: one aimed at the initial post-injury period and a second focusing on the stable post-insult period

Dean Faculty of Pain Medicine 2015 – 2018. Consultant and Medical Director Pain Medicine, St. James’ Hospital, Dublin. Primary Investigator, Trinity College Institute of Neuroscience. Senior Lecturer, School of Medicine, Trinity College, Dublin. Editor: BJA; Continuing Medical Education. Pain Clinic, Blackrock Clinic 2004 – date. Graduated RCSI 1988. Trained in Ireland, UK and Karolinska Institute, Stockholm and Lund University Hospital, Sweden.

Spinal Neuronal,Chronic Pain, Cancer Pain

Hans von Holst received his Medical Doctor´s degree in 1976 and specialist in Neurosurgery 1982 at Karolinska University Hospital. In 1985 he earned his PhD and Associate Professorship in Neurosurgery, Clinical Neuroscience at Karolinska Institutet. During 1991-1996 he was appointed as Chairman of the Dept of Neurosurgery and Division Manager of the Neuroclinics at Karolinska University Hospital, respectively. In 1995 he became Professor in Neuroengineering at the Royal Institute of Technology. He has published around 140 original papers in reputed journals, reviews and books and has been serving as an editorial board member in several journals.

traumatic brain injury and stroke

Ru-Rong Ji, Ph.D., is a professor of anesthesiology. He also serves as chief of pain research in the Department of Anesthesiology. He previously was an associate professor at Brigham and Women’s Hospital, Harvard Medical School, before joining the Duke faculty in 2012. His research focuses on molecular and cellular mechanisms of chronic pain, such as inflammatory pain, neuropathic pain, and cancer pain. He is internationally recognized for his contributions to demonstrating critical roles of MAP kinase signaling pathways and glial cells in the pathogenesis of chronic pain. His recent work has demonstrated powerful antinociceptive actions of pro-resolution lipid mediators (e.g., resolvins). Dr. Ji lectures internationally and reviews papers for numerous international journals. He also serves on National Institutes of Health review panels and the editorial boards of Pain, Neuroscience, and Neuroscience Bulletin. Dr. Ji earned a Ph.D. in neurobiology at Shanghai Institute of Physiology and completed postdoctoral training at Peking (Beijing) University Medical School, Karolinska Institute, and Johns Hopkins University School of Medicine. He later joined Massachusetts General Hospital as an instructor.

Inflammatory pain, neuropathic pain, and cancer pain

After his BSc Honours and an MSc in theoretical mathematics, Professor Toro obtained a PhD in computational mathematics applied to fluid dynamics. Since then, much of his research has been centred on the numerical analysis of partial differential equations and aerospace, industrial, environmental and medical applications. He is author of almost 300 works and has received several awards, including two honorary doctorates and the honorary title OBE from her majesty The Queen Elizabeth II. Prof. Toro’s current research is focused on the bio-physics of neurological diseases and their potential link to venous haemodynamics and transport across the blood vessel wall

Neurodegenerative diseases

Mark S. Kindy, Ph.D. is Professor of Neurosciences at the Medical University of South Carolina, Adjunct Professor of Bioengineering at Clemson University, Adjunct Professor of Chemical Engineering at the University of South Carolina, Adjunct Professor of Management and Entreprenurialism, School of Business, College of Charleston. He received his BA in zoology from the University of Massachusetts in 1980. Dr. Kindy received his Ph.D. in Biochemistry from Boston University School of Medicine from 1982-1987. He was a post-doctoral fellow at the Salk Institute from 1987-1989 in Molecular Biology and Virology. From 1989-2002, Dr. Kindy was a faculty member in the Department of Biochemistry at the University of Kentucky and rose from Assistant Professor to Full Professor. Dr. Kindy is currently the Admiral Pihl Endowed Professor in the Department of Neurosciences. Dr. Kindy is also a Research Career Scientist at the Ralph H. Johnson VA Medical Center in Charleston. Dr. Kindy has served on many NIH, AHA, AA review panels, has reviewed for many journals and is currently on the editorial board of 10 journals. Dr. Kindy has over 140 peer reviewed publications and is funded by the NIH, VA , NSF and several foundations.

Neurological disorders

Dr. Hernández, Ph.D. has been studying traumatic brain injury (TBI) using basic and clinical neuroscience models since 1985. Her ongoing, extramurally funded research program assesses the degree to which recovery and functional outcome after TBI can be optimized in a variety of populations (Veterans, civilians, athletes). This includes conducting randomized, placebo-controlled, blinded trials of novel interventions, such as acupressure. This work is accomplished through her appointment as Professor and Chair of the Department of Psychology & Neuroscience at CU Boulder, her appointment as a Senior Investigator and Research Psychologist in the Eastern Colorado Healthcare System, Rocky Mountain MIRECC (Mental Illness, Research, Education & Clinical Center) and through her role as one of the co-Directors of the PAPRR (Promoting Athlete Performance, Recovery and Resilience) Board at CU Boulder. She is also the Director of the CAIRR (Clinical Assessment of Injury, Recovery and Resilience) Neuroscience Laboratory.

ur clinically-based program of research is aimed at providing an experimental basis for improving clinical treatment following brain insult so that neurobehavioral function is optimized. We are currently accomplishing this via two tracks: one aimed at the initial post-injury period and a second focusing on the stable post-insult period.

Chris Gamblin completed his PhD with Dr. Robley Williams, Jr. at Vanderbilt University and postdoctoral studies with Dr. Skip Binder at Northwestern University Feinberg School of Medicine. He is currently an Associate Professor in the Department of Molecular Biosciences at the University of Kansas and continues to investigate the biochemical mechanisms of tau aggregation.

Dr Davide V Moretti is consultant neurologist, chief of the clinical neurophysiology service and researcher at the National Institute of Research and Cure for Mental disorders and Dementia S john of God, Brescia, Italy. He received his medical degree from Catholic University in Rome and completed his residency in neurology and fellowship in movement disorders at University of Trieste, Italy. Moreover, he received the PhD in neurophysiology at La Sapienza University (thesis title “ Quantitative EEG in Alzheimer's disease”). Dr Moretti is currently involved in research and care of subjects with Alzheimers disease and dementia in the Memory Clinic/Alzheimer Operative Unit of the S. John of God Institute. Moreover, he is the chief of the clinical neurophysiology unit. His research is primary concerned about quantitative EEG evaluation of Alzheimer's patients both in prodromic and clinically evident phase of the disease.

Alzheimers disease and dementia

Dr Wayne Grant Carter received his Honours degree and PhD in Biochemistry from the University of Southampton, studying protein post-translational modification and molecular signalling cascades. He is currently a Group Leader in the School of Medicine, University of Nottingham, with research focused upon protein post-translational modification and molecular mechanisms of hepato- and neuro-toxicity.

Rocco de Filippis completed his MD and PhD from Catholic University of the Sacred Heart in Rome. Investigator Meeting (Western Europe and North America) for BRENDA/pharmacological Study on Nalmefene (LUNDBECK - pharmaceutical company). Barcellona (Spagna) . He holds a Master’s degree and he improved respectively in Bipolar Disorders and Addictive behavior in the years 2011/2012. He currently works and at the Institute of Psychopathology - Rome as a Psychiatrist and Addictive Medicine, and up to now presented as scientific coordinator of CME and Master of Addictive Behaviors; he currently publishes on Bipolar Disorders with high specialization on rapid cycling;he is also an official candidate at the Psychoanalytic Italian Society of the First Italian Center of Rome, and member of IPSO (International Psychoanalytic Studies Organization). He had a oral speech at Translational Medicine 2014 in Las Vegas on QTc Prolungation and Psychotropic Drugs.

AJA Groffen has completed his PhD at the age of 29 years from the University Medical Center in Nijmegen, The Netherlands and performed postdoctoral studies at the University Medical Center Utrecht, The Netherlands. He was appointed Assistant Professor at the dept. of Clinical Genetics (section Functional Genomics) at the VU University Medical Center in Amsterdam, The Netherlands. He has published more than 25 papers in reputed journals.

movement disorders, epilepsies, cognitive and autism-related disorders

HND qualification at Cambridge Polytechnical College, Cambridge, UK (1971), Honour’s degree (Psychology and Physiology) at Newcastle-upon-Tyne University (1974), and PhD, Uppsala University, Uppsala, Sweden (1979), Astra Läkemedel AB ( Head of CNS Drugs), Professor and Chair of Biological Psychology, Head of Department and Dean of Faculty, Visiting Professor at: University of Hawaii at Manoa, Örebro University, Karlstad University, Kalmar University, Madrid University, Outstanding Lifetime Achievement Award from St. Joseph’s College, North Point; Honorary Doctorship and Professorship (Polish Academy of Science Pharmacological Society), Sansone Award, School of Medicine, Washington University, St. Louis, Missouri.

laboratory models of neurocritical care, arousal from coma, cardiac arrest, electrophysiology, neuropharmacology, orexin, global cerebral ischemia, neuroplasticity, neural monitoring devices, translational research, clinical trials

Weidong Le, MD, PhD, is a neurologist/neuroscientist with the major research interest in neurodegenerative disorders including Parkinson’s disease, Alzheimer’s disease and ALS. His research focus is cellular and molecular basis of neuronal injury in these neurodegenerative diseases. He was a Professor in Baylor College of Medicine and since 2013 he has been appointed as a Director of Center for Translational Research of Neurology Disease, and Vice President of 1st Affiliated Hospital, Dalian Medical University. He has published over 185 SCI papers in peer review journals and 7 scientific books.

Brain Imaging, Neuropsychiatry

Dr. Toborek has completed his MD and PhD from the Silesian Medical University, Poland, and completed his postdoctoral training at the University of Kentucky. He is the Vice-Chair for Research in the Department of Biochemistry and Molecular Biology. Research in Dr. Toborek’s laboratory has been focused on several aspects of vascular biology. Specific interest involves studies on the integrity of the blood-brain barrier (BBB) and how different pathological conditions can lead to the disruption and/or dysfunction of the BBB. He has published numerous manuscripts related to this field and has been serving as an editorial board member of many journals.

Dr. Toborek’s laboratory involve studies on the integrity of the blood-brain barrier (BBB) and how different pathological conditions can lead to the disruption and/or dysfunction of the BBB.

Dr. Othman Ghribi is an Associate professor at the Department of Pharmacology, Physiology and Therapeutics, University of North Dakota School of Medicine and Health Sciences, USA. He obtained his PHD degree in Neuropharmacology from Rene Descartes University, Paris, France in 1994. He published four book chapters, invited review papers and has more than 50 publications in different peer reviewed journals. Dr. Ghribi holds grants from the Centers of Biomedical Research Excellence and the National Institute of Environmental health Sciences/The National Institute of Health. Dr Ghribi obtained the Alzheimers and Related Diseases Research Award from the Virginia Center on Aging as well as the Dean David Wilson Academic Award in Neuroscience from the University of North Dakota.

Othman Ghribis Interests include role of the diet and environmental factors in Alzheimers and Parkinsons diseases, Tyrosine hydroxylase, alpha-synuclein, LXRs, Estrogen receptors, Oxysterols, Endoplasmic reticulum stress, Apoptosis, IGF-1, Leptin.

Dr. F.W. van Leeuwen, PhD is a neuroscientist with over 150 peer-reviewed scientific papers to his name. His team works at the University Maastricht. He was trained as a neurobiologist and obtained his PhD degree in 1980. After branching out into the field of molecular neurobiology in the nineties, he discovered a new mechanism, dubbed molecular misreading; the inaccurate conversion of genomic information into aberrant transcripts and mutant proteins (e.g. mutant ubiquitin B, UBB+1). These appeared to be present in the hallmarks (e.g. plaques and tangles) of sporadic Alzheimer and Down syndrome patients, but not in young non-demented controls. This was the cover story of Science 279, January 9th, 1998. The message is that the mutant proteins accumulate and contribute to neuronal dysfunctioning, e.g. by inhibiting the ubiquitin-proteasome system. This article has been named a “milestone paper”, and Dr. van Leeuwen has been invited to participate in an Alzheimer-100 book because it was 100 years ago that Dr. Alzheimer published his first article on the disease.

Neurodegenerative disorders,Down syndrome,Alzheimer’s disease

Professor Nazıroğlu has graduated from Veterinary Faculty, Fırat University (FU) at 1991 and he received his PhD (Physiology) in FU (1992-1996). Currently, he is working as Heads of Departments of Biophysics and Neurosciences in Suleyman Demirel University (SDU), Medical Faculty. As chair of congress, he organized 1st, 2nd, 3rd, 4th and 5th biennale International Congress in Cell Membrane and Oxidative Stress: Focus on Calcium Signaling and TRP channels since 2006, Isparta, Turkey. (www.cmos.org.tr). He is serving as an editorial member of several reputed journals like ‘Biological Trace Element Research’. He is also review editor in Frontiers in Membrane Physiology and Biophysics. He authored 188 international research and 11 review articles and 2852 citations in SCI-Thompson and 6 international book chapters. He has honored as NATO Research Fellowship, Martin-Luther University, Halle-Saale, Germany, (1999-2000), ‘Young Investigative Scientist Award (2001), UC-Berkeley, USA, Alexander von Humboldt (AvH) Research fellowship owner (2002-2005), Medical Faculty, RWTH-Aachen, Germany, Encouragement Award of Scientific and Tech. Res. Council (TUBITAK), Ankara, Turkey (2006), Howard Hudges Medical Institute (USA) support (2009) and Khwarizmi International Award (2012).

Epilepsy

Piotr Lewczuk heads the Laboratory for Clinical Neurochemistry and Neurochemical Dementia Diagnostics at the Department of Psychiatry and Psychotherapy Universitatsklinikum Erlangen. This lab is one of the mostly internationally recognized European leading centers for neurochemical diagnosis of dementia. The Laboratory is one of the five world-wide reference centers, together with the laboratories in Göteborg (S), Amsterdam (NL), Ghent (B), and Philadelphia (USA), in the Alzheimers Association supported project on CSF biomarkers international quality control. He is a member of the Steering Committee of this project. For more than ten years he has been working on diagnostic and research aspects of the CSF, including a large panel of neurologic and psychiatric disorders with a particular scope on neurodegenerating conditions, like Alzheimers disease.In 2004, he obtained the Certificate of Expertise from the German Society of Clinical Neurochemistry, to become one of seventy certified clinical neurochemists in Germany, and currently he is a member of the Extended Board of the German Society of Clinical Neurochemistry. Dr Lewczuk is also a member of the Scientific Advisory Board of the Alzheimer Diagnostic and Therapy Center at the Medical University of Wroclaw Poland in Scinawa and a consultant of a worldwide leading diagnostic biotech company Innogenetics Ghent Belgium.